Dr. Michaelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St
Cox 640 Hematology Oncology
Boston, MA 02114Phone+1 617-726-5187Fax+1 617-724-3166- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2000 - 2002
- Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 2000
- Albert Einstein College of MedicineClass of 1997
Certifications & Licensure
- NH State Medical License 2021 - 2025
- MA State Medical License 1999 - 2024
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer Start of enrollment: 2005 Jul 26
- Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma Start of enrollment: 2007 Dec 01
- Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Cardiac Structural Changes and Declining Cardiorespiratory Fitness During Androgen Deprivation Therapy for Prostate Cancer.Richard J Lee, Erika Meneely, Kara Olivier, Aaron L Baggish, Timothy W Churchill, Matthew R Smith, M Dror Michaelson, James Sawalla Guseh, Meagan M Wasfy, Philip J Saylor> ;Journal of the American Society of Echocardiography. 2024 Mar 16
- The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastati...Kozin, S., Matsui, A., Goldberg, S., Aoki, S., Shigeta, K., Mamessier, E., Lee, R., Duda, D., Saylor, P., Smith, M., Michaelson, M.> ;Radiotherapy and Oncology. 2024 Mar 1
- 5 citationsThe Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma.B A McGregor, G P Sonpavde, L Kwak, M M Regan, X Gao, H Hvidsten, C M Mantia, X X Wei, J E Berchuck, S A Berg, P K Ravi, M D Michaelson, T K Choueiri, J Bellmunt> ;Annals of Oncology. 2024 Jan 1
- Join now to see all
Hospital Affiliations
- Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: